The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
(Reuters) - The U.S. government will consider opportunities to "bring greater transparency" for the Medicare drug price ...
The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...
Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...
The National Community Pharmacists Association (NPCA) is warning the feds that independent pharmacists are likely to face ...
Minnesota Senator Amy Klobuchar is urging the Trump administration to continue negotiating lower prescription drug prices for ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results